Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: CYTOPRIME 2 Study ×

CYTOPRIME 2 Study

This institution is selected. Its supporting articles are shown below.

CYTOPRIME 2 Study1

Articles mentioning CYTOPRIME 2 Study

1 articles · page 1 of 1

Feasibility of primary care-based early detection of Barrett’s oesophagus and oesophageal adenocarcinoma in patients with reflux using capsule sponge testing: real-world insights from the CYTOPRIME 2 Study

flgastro · abstract · 2026-05-06 · 1 matching annotations

88.5%

CYTOPRIME 2 Study Gastro-oesophageal reflux disease (GORD)Oesophageal adenocarcinoma (OAC)Barrett’s oesophagus (BO)

… and p53 have demonstrated performance for diagnosis of BO. The CYTOPRIME 2 Study was designed to assess the feasibility of implementing this tes…

Browse institutions

CYTOPRIME 2 Study

Articles mentioning CYTOPRIME 2 Study

Feasibility of primary care-based early detection of Barrett’s oesophagus and oesophageal adenocarcinoma in patients with reflux using capsule sponge testing: real-world insights from the CYTOPRIME 2 Study